Access comprehensive trade data for Tov Rosh Ukraine with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Eximpedia analyzes Tov Rosh Ukraine export and import records, including data from 0 buyers and 4 suppliers. We provide an intelligence report of Tov Rosh Ukraine that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Tov Rosh Ukraine import markets
Explore the Tov Rosh Ukraine import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
HS CODE | USD VALUE | SHIPMENTS | % |
---|---|---|---|
3002150000 | 28.99 | 26 | 44.83 |
HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
3004900000 | 12.47 | 18 | 31.03 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
3004500000 | 9.06 | 3 | 5.17 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
3004390000 | 0.37 | 7 | 12.07 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
9025190090 | 0.00 | 1 | 1.72 |
HYDROMETERS AND SIMILAR FLOATING INSTRUMENTS, THERMOMETERS, PYROMETERS, BAROMETERS, HYGROMETERS AND PSYCHROMETERS, RECORDING OR NOT, AND ANY COMBINATION OF THESE INSTRUMENTS |
COUNTRY | USD VALUE | SHIPMENTS | % |
---|---|---|---|
GERMANY | 27.24 | 29 | 50.00 |
SWITZERLAND | 13.14 | 11 | 18.97 |
UNITED STATES | 5.28 | 5 | 8.62 |
JAPAN | 3.69 | 7 | 12.07 |
FRANCE | 0.64 | 1 | 1.72 |
PORT NAME | USD VALUE | SHIPMENTS | % |
---|---|---|---|
UA100200 | 50.90 | 54 | 93.10 |
UA100390 | 0.00 | 3 | 5.17 |
UA100290 | 0.00 | 1 | 1.72 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
ASTRAZENECA PHARMACEUTICALS LLC | 253.12 | 526 |
JSC R FARM | 346.89 | 560 |
CJSC ROCH MOSCOW | 381.03 | 196 |
LLC NAUKA MEDICINE VETERINARY | 43464.58 | 134 |
TOV ALSI LTDKYIV | 248396.75 | 5287 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
CELLSYSTEMS GMBH | 3116.18 | 2 |
MY BIOTECH SRO | 40348.40 | 20 |
WALTER FRIES TRADE AND TRANSPORT | 100422.83 | 1803 |
TH GEYER GMBH AND CO KG | 117078.48 | 3096 |
If you are looking to establish relationship with Tov Rosh Ukraine Automation you can save time by getting access to the key decision makers and get a detailed report.
Discover the Tov Rosh Ukraine with product description, import values, quantities, exporter name, country of origin and key destinations.
HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
---|---|---|---|---|---|---|
3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL TRADE: - PULMOZIM(R), SOLUTION FOR INHALATION, 2.5 MG/2.5 ML, 2.5 ML IN AN AMPOULE; 6 AMPOULES IN A CONTAINER; 1 CONTAINER IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES: 1 AMPOULE (2.5 ML) OF SOLUTION FOR INHALATION CONTAINS: DORNASE ALFA 1 2.5 MG 1), 1 MG OF DORNASE ALFA CORRESPONDS TO 1000 UNITS) - ARTICLE: 10243308 SERIES: N0021B35 - 160 UNITS MANUFACTURER: PRIMARY PACKAGING, VIAL UNDEVELOPED PRODUCTS: WOODSTOCK STERILE SOLUTIONS INC., USA, SECONDARY PACKAGING, SERIES RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND, QUALITY CONTROL TESTING: ROCHE DIAGNOSTICS GMBH, GERMANY COUNTRY OF MANUFACTURE: USTRADEMARK: ROCHE, PULMOZIM""" | UNITED STATES | UKRAINE | 0 | ||
3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - FESGO(R), SOLUTION FOR INJECTIONS, 1200 MG/600 MG PER 15 ML SOLUTION FOR INJECTIONS IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: PERTUZUMAB 1200 MG, TATRASTUZUMAB 600 MG IN 15 ML) - ARTICLE: 10228797 SERIES: B1303B09 - 15 UNITS - ARTICLE: 10228797 SERIES: B1303B18 - 16 UNITS - FESGO(R), SOLUTION FOR INJECTION, 600 MG/600 MG PER 10 ML SOLUTION FOR INJECTION IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: PERTUZUMAB 600 MG, TATRASTUZUMAB 600 MG IN 10 ML) - ARTICLE: 10228878 SERIES: B1309B11 - 165 UNITS MANUFACTURER: """"F. HOFFMANN-LA ROCHE LTD., SWITZERLAND. COUNTRY OF MANUFACTURE: CHTRADE MARK: ROCHE""" | SWITZERLAND | UKRAINE | 0 | ||
3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - GAZIVA(R), CONCENTRATE FOR SOLUTION FOR INFUSION, 1000 MG/40 ML OF 40 ML IN A BOTTLE; 1 BOTTLE IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 BOTTLE CONTAINS: 1000 MG OF OBINUTUZUMAB, WHICH CORRESPONDS TO THE CONCENTRATION BEFORE DILUTION OF 25 MG/ML) - ARTICLE: 10152192 SERIES: H0240B32 -178 UNITS MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: ROSH DIAGNOSTICS GMBH, GERMANY; SECONDARY PACKAGING, SERIAL RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND COUNTRY OF MANUFACTURE: DETRADE MARK: ROCHE, GAZIVA""" | GERMANY | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - ZELBORAF(R), FILM-COATED TABLETS, 240 MG EACH, 8 TABLETS IN A BLISTER; 7 BLISTERS IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: VEMURAFENIB 240 MG IN THE FORM OF A CO-PRECIPITATE OF VEMURAFENIB AND HYPROMELLOSE ACETATE SUCCINATE (RATIO 3:7) - ARTICLE: 10206036 SERIES: M1384MJ - 120 UNITS MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, SECONDARY PACKAGING , QUALITY CONTROL TESTS : DELPHARM MILANO S.R.L., ITALY; PRODUCTION SERIES: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND COUNTRY OF MANUFACTURE: ITTRADEMARK: ROCHE, ZELBORAF""" | ITALY | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - KOTELLIC, FILM-COATED TABLETS, 20 MG EACH, 21 TABLETS IN A BLISTER; 3 BLISTERS EACH IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: COBIMETINIB 20 MG IN THE FORM OF COBIMETINIB HEMIFUMARATE 22.20 MG) - ARTICLE: 10213155 SERIES: B5009M3 -21 UNITS MANUFACTURER: QUALITY CONTROL TEST AT RELEASE (MICROBIOLOGICAL PURITY); SERIES RELEASE: F. HOFFMANN-LA ROCHE, SWITZERLAND; PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL TESTS FOR STABILITY: DELFARM MILANO, S.R.L., ITALY; PRODUCTION OF BULK PRODUCTS, QUALITY CONTROL TESTS FOR STABILITY AND RELEASE (EXCEPT FOR MICROBIOLOGICAL PURITY) EXCELLA GMBH & CO.KG, GERMANY. COUNTRY OF MANUFACTURE: DETRADEMARK: ROCHE""" | GERMANY | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - TAMIFLU(R), CAPSULES OF 75 MG, 10 CAPSULES IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 CAPSULE CONTAINS: OSELTAMIVIR 75.00 MG IN THE FORM OF OSELTAMIVIR PHOSPHATE 98.50 MG) - ARTICLE: 10177339 SERIES: F0241B10-25200UP MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS: SENEXI SAS, FRANCE; PACKAGING, QUALITY CONTROL TESTING, RELEASE SERIES: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND. COUNTRY OF MANUFACTURE: FRTRADE MARK: ROCHE, TAMIFLU""" | FRANCE | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - VALCYT(R), FILM-COATED TABLETS, 450 MG, 60 TABLETS IN A BOTTLE; 1 BOTTLE IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES: 1 TABLET CONTAINS: VALGANCICLOVIR 450.0 MG IN THE FORM OF VALGANCICLOVIR HYDROCHLORIDE 496.3 MG) - ARTICLE: 10159386 SERIES: N0502B02 - 500 UNITS MANUFACTURER: SECONDARY PACKAGING, PRODUCTION SERIES: F.HOFFMANN-LA ROCHE LTD, SWITZERLAND; PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: PATHEON INC., CANADA COUNTRY OF MANUFACTURE: CATRADEMARK: ROCHE, VALTSIT | CANADA | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - GEMLIBRA, SOLUTION FOR INJECTIONS OF 30 MG/1 ML, 1 ML (30 MG) IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 30 MG/1MLEMICIZUMAB) - ARTICLE: 10220477 SERIES: B0165B05 - 1 PACK MANUFACTURER: QUALITY CONTROL TESTING, SECONDARY PACKAGING, SERIES RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND; PRODUCTION OF BULK PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: CHUGAI PHARMA MANUFACTURING CO., LTD., JAPAN. COUNTRY OF MANUFACTURE: JPTRADEMARK: ROCHE | JAPAN | UKRAINE | 0 | ||
3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE: - OKREVUS(R), CONCENTRATE FOR SOLUTION FOR INFUSION 300 MG/10 ML, 10 ML IN A BOTTLE; 1 BOTTLE IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 BOTTLE (10 ML OF CONCENTRATE FOR SOLUTION FOR INFUSION) CONTAINS : 300 MG OCRELIZUMAB)- ARTICLE: 10228524 SERIES: H0076B18 -438 UNITS MANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, QUALITY CONTROL TESTING: ROSH DIAGNOSTICS GMBH, GERMANY; SECONDARY PACKAGING, SERIAL RELEASE: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND COUNTRY OF MANUFACTURE: DETRADE MARK: ROCHE, OKREVUS | GERMANY | UKRAINE | 0 | ||
3004900000 | 1. PHARMACEUTICAL PRODUCTS - EMICIZUMAB 30 MG, WHICH IS SUPPLIED AS PART OF THE IMPLEMENTATION OF PROGRAMS AND THE IMPLEMENTATION OF CENTRALIZED HEALTH CARE MEASURES, NAMELY IN THE DIRECTION OF PREVENTION, DIAGNOSIS AND TREATMENT ""MEDICINES FOR THE PROVISION OF CHILDREN WITH HEMOPHILIA A OR WILLEBRAND'S DISEASE; MEDICINAL PRODUCTS FOR THE PROVISION OF ADULTS, PATIENTS WITH HEMOPHILIA TYPES A OR B OR WILLEBRAND'S DISEASE"""" ACCORDING TO THE BUDGET PROGRAM KPKVK 2301400 """"PROVISION OF MEDICAL MEASURES OF SEPARATE STATE PROGRAMS AND COMPLEX MEASURES OF A PROGRAMMATIC NATURE"""". MEDICINAL PRODUCTS FOR PEOPLE, THERAPEUTICALLY PACKAGED FOR RETAIL TRADE: - GEMLIBRA, SOLUTION FOR OTHER INJECTIONS OF 30 MG/1 ML OF 1 ML (30 MG) IN A BOTTLE; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL CONTAINS: 30 MG/1 MLEMICIZUMAB) - ARTICLE: 10220477 SERIES: B0165B05 - 441 UNITS (CALCULATED PER MG - 13230 MG) MANUFACTURER: QUALITY CONTROL TEST, SECONDARY PACKAGING, SERIES RELEASE: ? .HOFFMANN-LA ROCHE LTD., SWITZERLAND; PRODUCTION OF UNPACKAGED PRODUCTS, TRANS" | JAPAN | UKRAINE | 0 | ||
3002150000 | 1. MEDICINES FOR HUMANS, IMMUNOLOGY, PACKAGED FOR RETAIL SALE: - HERCEPTIN(R), SOLUTION FOR INJECTION, 600MG/5ML 1 VIAL WITH SOLUTION IN A CARTON (ACTIVE INGREDIENTS: 1 VIAL (5ML) CONTAINS: UMABU600MG)-ARTICLE: 10143401 SERIES: B1818B20 -127 MANUFACTURER: MANUFACTURE OF UNPACKAGED PRODUCTS, PACKAGING, QUALITY CONTROL TESTING, BATCH RELEASE: F. HOFFMANN-LA ROCHE LTD, SWITZERLAND COUNTRY OF MANUFACTURE: CH TRADEMARK: ROCHE, HERTZEPT IN-TECENTRIC(R), CONCENTRATE FOR SOLUTION FOR INFUSION PO 1200MG/20ML PO 20ML VIAL; 1 VIAL IN A CARTON (ACTIVE INGREDIENTS: 1 VIAL (20ML CONCENTRATE FOR SOLUTION FOR INFUSION) CONTAINS: 1200MG ATEZOLIZUMAB) - ITEM: 10227497 SERIES: B0046B07 -137 MANUFACTURER: MANUFACTURER UNPACKAGED PRODUCTS, PRIMARY PACKAGING, EXTR. QUALITY CONTROL: ROSH DIAGNOSTICS GMBH, GERMANY; EXERCISE OF QUALITY CONTROL, SECOND. PACKAGING, BRAND ISSUED: F. HOFFMANN-LA ROCHE LTD, SWITZERLAND MANUFACTURER: CH TRADE BRAND: TECENTRIK-POLAYVI(R), POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION OF 30 MG IN A VIAL; 1 VIAL IN A CARDBOARD BOX (AC TIVE SUBSTANCES : 1 VIAL CONTAINS 30 MG POLATUZUMAB VEDOTIN; 1 ML OF PREPARED (RECONSTRUCTED) SOLUTION CONTAINS POLATUZUMAB VEDOTIN 20 MG/ML)-ARTICLE: 10232391 SERIES: B1024B09 -10 MANUFACTURER: """"F. HOFFMANN-LA ROCHE LTD"""", SWITZERLAND COUNTRY OF MANUFACTURE: CHTRADE BRAND: ROCHE, POLAIVI-FESGO (R), SOLUTION FOR INJECTION, 1200 MG/600 MG, 15 ML IN A VIAL, 1 VIAL IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 VIAL CONTAINS: PERTUZUMABA 1200MG, TRASTUSUMABA 600MG AND RECOMBINANT HUMAN HYALURONIDASE (RHUPH20) 30000 UNITS)-ARTICLE: 10228797 SERIES: B1306B38 -41UP-FESGO (R), SOLUTION FOR INJECTION, 600 MG/600 MG, BY 10 ML IN A VIAL , 1 VIAL IN A CARTON BOX (ACTIVE INGREDIENTS: 1 VIAL CONTAINS: PERTUZUMABA 600MG, TRASTUSUMABA 600MG AND RECOMBINANT HUMAN HYALURONIDASE (RHUPH20) 20000 UNITS) - ITEM: 10228878 SERIES: B1316B09 -217UPPRODUCER: """"F. HOFFMANN-LA ROCHE LTD"""", SWITZERLAND. COUNTRY OF MANUFACTURE: CH TRADEMARK: ROCHE, FESGO | SWITZERLAND | UKRAINE | 0 | ||
3002150000 | 1. MEDICINES FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: -AVASTIN(R), CONCENTRATE FOR SOLUTION FOR INFUSION, 100MG/4ML PER 4ML (100MG) VIAL; 1 VIAL IN A CARTON (ACTIVE INGREDIENTS: 1 VIAL (4ML CONCENTRATE FOR INFUSION) CONTAINS: 100MG (25MG/ML) BEVACISUMAB; 1 VIAL (16ML CONCENTRATE FOR INFUSION) CONTAINS: 400MG (25MG/ML) BE VACIZUMABU)-ARTICLE: 10194313 SERIES: H0387B42 -1375 MANUFACTURER: PRIMARY PACKAGING, SECONDARY PACKAGING AND BATCH RELEASE: """"F.HOFFMANN-LA ROCHE LTD"""", SWITZERLAND; PRODUCTION OF UNPACKAGED PRODUCTS, QUALITY CONTROL TESTING: """"ROSH DIAGNOSTICS GMBH"""", GERMANY. COUNTRY OF PRODUCTION: DE TRADEMARK: ROCHE, AVASTYN | GERMANY | UKRAINE | 0 | ||
3004390000 | 1. MEDICINES FOR HUMANS CONTAINING HORMONES PACKAGED FOR RETAIL SALE:-RECORMON(R), SOLUTION FOR INJECTION 30000 IU/0.6ML IN 1 PRE-FILLED SYRINGE OF 30000 IU/0.6ML WITH NEEDLE FOR IN 'ECTION 27 G1 /2(NEEDLE PLACED IN PLASTIC PACKAGING);IN CONTOUR BLISTER PACKAGING CONSISTING OF 1 PLASTIC CONTAINER (1 PRE-FILLED SYRINGE AND 1 NEEDLE IN ONE PLASTIC CONTAINER); 1 CIRCULAR PACK (1 PRE-FILLED SYRINGE AND 1 NEEDLE) IN A CARTON (ACTIVE INGREDIENTS: 1 PRE-FILLED SYRINGE (0.6ML SOLUTION) CONTAINS: EPOETIN BETA 30000 IU (250 MCG) - ITEM: 1 0246986 SERIES: H1019H08 -94UP MANUFACTURER: UNPACKED PRODUCTION PRODUCTS, SECONDARY PACKAGING, QUALITY CONTROL TESTING, BATCH RELEASE: ROCHE DIAGNOSTICS GMBH, GERMANY COUNTRY OF MANUFACTURE: DE TRADEMARK: ROCHE, REKORMON | GERMANY | UKRAINE | 0 | ||
3004500000 | 1. MEDICINES FOR HUMANS CONTAINING VITAMINS, PACKAGED FOR RETAIL SALE:- ROACCUTAN(R), 10MG CAPSULES, 10 CAPSULES IN BLISTERS; 3 BLISTERS IN A BOX (ACTIVE INGREDIENTS: 1 CAPSULE CONTAINS: 10MG ISOTRETINOIN)-ARTICLE: 10198671 SERIES: B9268B03-34955UP-ROACCUTAN(R), 20MG CAPSULES, 10 CAPSULES IN A BLISTER; 3 BLISTERS IN A BOX (ACTIVE INGREDIENTS: 1 CAPSULE-ARTICLE:10198627 SERIES:B9881B03-11364UP-ARTICLE:10198627 SERIES:B9882B01-26996UPMANUFACTURER: PRODUCTION OF UNPACKAGED PRODUCTS, PRIMARY AND SECONDARY PACKAGING: KETELENT GERMANY EBERBACH, GERMANY; QUALITY CONTROL TESTING, BATCHES : F. HOFFMANN-LA ROCHE LTD, SWITZERLAND. COUNTRY OF MANUFACTURE: DE TRADEMARK: ROCHE, ROACCUTAN | GERMANY | UKRAINE | 0 | ||
3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - AVASTIN(R), CONCENTRATE FOR SOLUTION FOR INFUSIONS, 100 MG/4 ML PER 16 ML (400 MG) VIAL; 1 VIAL IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 VIAL (4 ML CONCENTRATE FOR INFUSION SOLUTION) CONTAINS: 100 MG (25 MG/ML) BEVACIZUMAB; 1 VIAL (16 ML CONCENTRATE FOR INFUSION SOLUTION) CONTAINS: 400 MG (25 MG/ML) BEVACIZUMAB) - ARTICLE: 10194470 SERIES: H0307B05 -1454UP MANUFACTURER: PRIMARY PACKAGING, SECONDARY PACKAGING, SERIAL RELEASE; QUALITY CONTROL TESTS (EXCEPT THE BEVACIZUMAB IDENTIFICATION TEST), """"F. HOFFMANN-LA ROCHE LTD., SWITZERLAND; PRODUCTION OF UNPACKAGED PRODUCTS, QUALITY CONTROL TESTING: """"ROCHE DIAGNOSTICS GMBH"""", GERMANY. COUNTRY OF MANUFACTURE: DETRADE MARK: ROCHE, AVASTIN-HERCEPTIN(R), 150 MG LYOPHILISATE FOR CONCENTRATE FOR INFUSION SOLUTION, 150 MG LYOPHILISATE FOR CONCENTRATE FOR INFUSION SOLUTION IN A BOTTLE, 1 BOTTLE IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 SINGLE-DOSE BOTTLE WITH LYOPHILISATE" | GERMANY | UKRAINE | 0 | ||
3004390000 | 1. MEDICINAL PRODUCTS FOR HUMANS CONTAINING HORMONES, PACKAGED FOR RETAIL SALE: - RECORMON(R), SOLUTION FOR INJECTION OF 2000 IU/0.3 ML IN 3 PRE-FILLED SYRINGES OF 2000 IU/0.3 ML TOGETHER WITH 3 NEEDLES FOR INJECTION 27 G1/2 (NEEDLE PLACED IN A PLASTIC PACKAGE) IN A CONTOURED BLISTER PACK CONSISTING OF 3 SEPARATE PLASTIC CONTAINERS (1 PRE-FILLED SYRINGE AND 1 NEEDLE IN ONE PLASTIC CONTAINER); 2 CONTOUR BLISTER PACKS (6 PRE-FILLED SYRINGES AND 6 NEEDLES) IN A CARDBOARD BOX (ACTIVE SUBSTANCES: 1 PRE-FILLED SYRINGE (0.3 ML OF SOLUTION) CONTAINS: EPOETIN BETA 2000 IU (16.6 ?G) - ARTICLE: 10247118 SERIES: H1053H10-1555UP MANUFACTURER : PRODUCTION OF UNPACKAGED PRODUCTS, SECONDARY PACKAGING, QUALITY CONTROL TESTING, SERIES RELEASE: ROSH DIAGNOSTICS GMBH, GERMANY. COUNTRY OF MANUFACTURE: DETRADE MARK: ROCHE, RECORMON | GERMANY | UKRAINE | 0 | ||
3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: - MIRCERA(R), SOLUTION FOR INJECTIONS OF 75 MCG/0.3 ML 1 PRE-FILLED SYRINGE TOGETHER WITH A NEEDLE FOR INJECTIONS IN A CARDBOARD PACKAGE (ACTIVE SUBSTANCES: 1 PRE-FILLED SYRINGE WITH 0 , 3 ML SOLUTION FOR INJECTIONS CONTAINS: 75 MCG OF METHOXY POLYETHYLENE GLYCOL - EPOETINUBETA) - ARTICLE: 10186040 SERIES: B3519H26-1544UP MANUFACTURER: """"PRODUCTION OF UNPACKAGED PRODUCTS, SECONDARY PACKAGING, QUALITY CONTROL TESTING, SERIES RELEASE: ROSH DIAGNOSTICS GMBH, GERMANY; QUALITY CONTROL TEST: F.HOFFMANN-LA ROCHE LTD., SWITZERLAND"""", SWITZERLAND. COUNTRY OF MANUFACTURE: CHTRADE MARK: ROCHE, MYRCERA-KADSILA(R), POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 160 MG 1 VIAL OF POWDER IN A CARDBOARD BOX (ACTIVE SUBSTANCES : 1 VIAL CONTAINS: TRASTUZUMAB EMTANSINE 160 MG FOR PREPARATION OF 8 ML CONCENTRATE FOR INFUSIONS CONTAINING TRASTUZUMAB EMTANSINE 20 MG/ML) - ARTICLE: 10158360 SERIES: B2817B08 -23 UNITS - ARTICLE: 10158360 SERIES: B3600B12 -27 UNITS MANUFACTURER: PRODUCTION" | SWITZERLAND | UKRAINE | 0 | ||
9025190090 | 1. ELECTRONIC DEVICE FOR MEASURING THE TEMPERATURE IN A WAREHOUSE, A THERMOMETER: -TEMPERATURE MONITORS TT ULTRA 16K AMB MU - STANDARD ART. .MANUFACTURER: SENSITECH UNITED TECHNOLOGIESTRADEMARK: SENSITECHCOUNTRY OF MANUFACTURE: CN""" | CHINA | UKRAINE | 0 | ||
3002150000 | 1. MEDICINES FOR HUMANS, IMMUNOLOGICAL, PACKAGED FOR RETAIL SALE: -AVASTIN(R), CONCENTRATE FOR SOLUTION FOR INFUSION, 100MG/4ML IN 16ML (400MG) VIAL; 1 VIAL IN A CARTON (ACTIVE INGREDIENTS: 1 VIAL (4ML CONCENTRATE FOR SOLUTION FOR INFUSION) CONTAINS: 100MG (25MG/ML) BEVACISUMAB; 1 VIAL (16ML CONCENTRATE FOR SOLUTION FOR INFUSION) CONTAINS: 400MG (25MG/ML) BEVA CIZUMABU)-ARTICLE: 10194470 SERIES: H0311B17 -1485UP MANUFACTURER: MANUFACTURE OF UNPACKAGED PRODUCTS, SECONDARY PACKAGING, QUALITY CONTROL EXAMINATION, BATCH RELEASE: ROSH DIAGNOSTICS GMBH, GERMANY; QUALITY CONTROL TESTING: F.HOFFMANN-LA ROCHE LTD, SWITZERLAND COUNTRY OF MANUFACTURE: DE TRADEMARK: ROCHE, AVASTIN-MABTERA(R), CONCENTRATE FOR SOLUTION FOR INFUSION, 100MG/10ML BY 10ML IN A VIAL; 2 VIALS IN A CARTON BOXES (ACTIVE INGREDIENTS: 1ML OF THE PREPARATION CONTAINS: 10MG RITUXIMABU; 1 VIAL (10MG) CONTAINS: 100MG RITUXIMABU)-ARTICLE:10132278 SERIES:H0347B28 -81UP-ARTICLE:10132278 SERIES:H0356B03 -201UP-MABTERA(R), CONCENT TRAT FOR SOLUTION FOR INFUSION, 100MG/10ML PO 50ML IN A VIAL; 1 VIAL IN A CARDBOARD BOX (500MG/50ML) (ACTIVE INGREDIENTS: 1ML PREPARATION CONTAINS: 10MG RITUXIMAB; 1 VIAL (50MG) CONTAINS: 500MG RITUXIMAB)-ARTICLE: 10130943 SERIES: H1110B0 5 -303UMANUFACTURER: SECONDARY PACKAGING, CONTROL TESTING QUALITY, SERIES ISSUE: F. HOFFMANN-LA ROSH LTD, SWITZERLAND; MANUFACTURING OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING, SECONDARY PACKAGING, QUALITY CONTROL TESTING, BATCH RELEASE: ROSHDIAGNOSTIX GMBH, GERMANY. COUNTRY OF MANUFACTURE: DE TRADEMARK: ROCHE, MABTERA | GERMANY | UKRAINE | 0 | ||
3002150000 | 1. HUMAN MEDICINES, IMMUNOLOGICAL, PACKAGED FOR RETAIL:- MYRCERA(R), SOLUTION FOR INJECTION PO 50MG/0.3ML 1 PRE-FILLED SYRINGE WITH INJECTION NEEDLE IN CARTON (ACTIVE INGREDIENTS CONTENTS: 1 PRE-FILLED SYRINGE WITH 0 ,3ML SOLUTION FOR INJECTION CONTAINS: 50MG METHOXY POLYETHYLENE GLYCOL - EPOETHINUBETA)-ARTICLE:10187041 SERIES:B3008H08 -728UP-MYRCERA(R), SOLUTION FOR INJECTION 75MG/0.3ML 1 PRE-FILLED W INSTRUMENT WITH NEEDLE FOR INJECTIONS IN A CARTON PACKAGING (ACTIVE INGREDIENTS: 1 PRE-FILLED SYRINGE WITH 0.3ML OF SOLUTION FOR INJECTION CONTAINS: 75 MG OF METHOXY POLYETHYLENE GLYCOL - EPOETIN BETA) - ITEM: 10186040 SERIES: B3520H01 -1802 MANUFACTURER: VUP PRODUCTION OF UNPACKAGED PRODUCTS, SECONDARY PACKAGING, EXAMINATION OF QUALITY CONTROL, ISSUE OF THE SERIES: ROSH DIAGNOSTICS GMBH, GERMANY; QUALITY CONTROL TESTING: F.HOFFMANN-LA ROCHE LTD, SWITZERLAND COUNTRY OF MANUFACTURE: CH TRADEMARK: ROCHE, MYRCERA-KADSILA(R), POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 160MG 1 VIAL POWDER IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 VIAL CONTAINS: TRASTUSUMABUEMTANSIN 160MG FOR THE PREPARATION OF 8ML OF CONCENTRATE FOR INFUSION CONTAINING TRASTUSUMAB EMTANSINE 20MG/ML)-ARTICLE: 10158360 SERIES: B3602B13 -35UP MANUFACTURER: ""MANUFACTURE OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING; SECONDARY PACKAGING; QUALITY CONTROL TESTING; ISSUE OF THE SERIES: F. HOFFMANN-LA ROCHE LTD"""", SWITZERLAND COUNTRY OF MANUFACTURE: CHTRADE BRAND: ROCHE, KADSILA-KADSILA(R), POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG 1 VIAL WITH POWDER IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 VIAL CONTAINS : TRASTUSUMABUEMTANSINE 100MG FOR THE PREPARATION OF 5ML CONCENTRATE FOR INFUSION CONTAINING TRASTUSUMAB EMTANSINE 20MG/ML)-ARTICLE: 10158357 SERIES: B3604B13 -193UP MANUFACTURER: ""MANUFACTURER OF UNPACKAGED PRODUCTS, PRIMARY PACKAGING; SECONDARY PACKAGING; QUALITY CONTROL TESTING; ISSUE OF THE SERIES: F. HOFFMANN-LA ROCHE LTD"""", SWITZERLAND COUNTRY OF MANUFACTURE: CHTRADE BRAND: ROCHE, KADSILA-FESGO (R), SOLUTION FOR INJECTION, 1200MG/600MG, 15ML IN A VIAL, 1 VIAL IN A CARDBOARD BOX (ACTIVE INGREDIENTS: 1 VIAL CONTAINS PERTUZUMABA 1200 MG TATRASTUSUMABA 600 MG IN 15 ML)-ARTICLE: 10228797 SERIES: B1306B03 -35UP-FESGO (R), SOLUTION FOR INJECTION, 600 MG/600 MG, 10 ML IN A VIAL AND, PO 1 VIAL IN A CARDBOARD BOX (1 VIAL CONTAINS PERTUZUMABA 600 MG AND TRASTUSUMABA 600 MGW 10 ML) - ITEM: 10228878 SERIES: B1313B11 -156UPMANUFACTURER: """"F. HOFFMANN-LA ROCHE LTD"""", SWITZERLAND COUNTRY OF MANUFACTURE: CH TRADEMARK: ROCHE, FESGO | SWITZERLAND | UKRAINE | 0 |
No Pay, No Delay - 5 days Your Way!
Learn How our platform works in just 20 minutes!
Free Import-Export Sample data-One Click Away!
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
See all that you can accomplish with Eximpedia